BioAge Labs, Inc.(BIOA:US)
Market Cap$214.83M
Key Metrics
Price$4.84
Revenue (TTM)$10.32M
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$89.93M
EBITDA (TTM)-$88.83M
Op. Margin (TTM)-985.93%
Dividend Yield-
Holders Yield-
Cash on hand$241.78M
Total Assets$397.65M
Net Assets$379.12M
Total Debt$4.03M
Key Metrics
Price$4.84
Revenue (TTM)$10.32M
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$89.93M
EBITDA (TTM)-$88.83M
Op. Margin (TTM)-985.93%
Dividend Yield-
Holders Yield-
Cash on hand$241.78M
Total Assets$397.65M
Net Assets$379.12M
Total Debt$4.03M
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $2.77M | $3.08M | $2.05M | $2.41M | $1.45M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - |
| $28.15M | $31.5M | $25.19M | $27.18M | $17.9M | $25.36M | $24.75M | $15.27M | $12.81M | $13.6M | $9.89M | $13.41M | $11.51M | |
| Research and Development | $20.41M | $24.5M | $18.51M | $19.84M | $11.11M | $19.23M | $20.02M | $10.47M | $9.32M | $10.08M | $6.53M | $9.23M | $8.04M |
| Selling, General, and Administrative | $7.74M | $7M | $6.68M | $7.34M | $6.79M | $6.14M | $4.73M | $4.8M | $3.49M | $3.51M | $3.36M | $4.18M | $3.47M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$25.38M | -$28.42M | -$23.14M | -$24.77M | -$16.45M | -$25.36M | -$24.75M | -$15.27M | -$12.81M | -$13.6M | -$9.89M | -$13.41M | -$11.51M |
| $3.12M | $2.48M | $2.97M | $3.21M | $3.52M | $4.23M | $1.34M | $1.69M | -$179K | -$7.36M | -$4.74M | -$3.78M | $421K | |
| Non-Operating Interest Income | $3.27M | $2.79M | $3.16M | $3.42M | $3.71M | $4.1M | $2.04M | $2.2M | $1.3M | $379K | $499K | $318K | $1.24M |
| Non-Operating Interest Expense | $39K | $92K | $149K | $201K | $255K | $319K | $388K | $443K | $1.22M | $2.56M | $2.4M | $2.04M | $793K |
| Other Income/Expense | -$107K | -$220K | -$42K | -$11K | $59K | $457K | -$306K | -$70K | -$258K | -$5.18M | -$2.83M | -$2.05M | -$21K |
Income Before Tax | -$22.25M | -$25.94M | -$20.17M | -$21.56M | -$12.93M | -$21.13M | -$23.41M | -$13.58M | -$12.99M | -$20.96M | -$14.63M | -$17.19M | -$11.08M |
Income Tax | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -$22.25M | -$25.94M | -$20.17M | -$21.56M | -$12.93M | -$21.13M | -$23.41M | -$13.58M | -$12.99M | -$20.96M | -$14.63M | -$17.19M | -$11.08M |
Minority Interests | - | - | - | - | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$22.25M | -$25.94M | -$20.17M | -$21.56M | -$12.93M | -$21.13M | -$23.41M | -$13.58M | -$12.99M | -$20.96M | -$14.63M | -$17.19M | -$11.08M |
Shares Outstanding (Basic) | 42.48M | - | 35.85M | 35.85M | 35.85M | - | 3.49M | - | 34.17M | - | 20.12M | - | 20.12M |
Shares Outstanding (Diluted) | 42.48M | - | 35.85M | 35.85M | 35.85M | - | 3.49M | - | 34.17M | - | 20.12M | - | 20.12M |
EPS (Basic) | -$0.52 | - | -$0.56 | -$0.60 | -$0.36 | - | -$6.70 | - | -$0.38 | - | -$0.73 | - | -$0.55 |
EPS (Diluted) | -$0.52 | - | -$0.56 | -$0.60 | -$0.36 | - | -$6.70 | - | -$0.38 | - | -$0.73 | - | -$0.55 |
EBIT | -$22.21M | -$25.85M | -$20.02M | -$21.36M | -$12.67M | -$20.81M | -$23.02M | -$13.14M | -$11.78M | -$18.4M | -$12.22M | -$15.15M | -$10.29M |
EBITDA | -$22.04M | -$25.56M | -$19.93M | -$21.29M | -$12.7M | -$21.22M | -$22.68M | -$13.02M | -$11.48M | -$13.18M | -$9.34M | -$13.05M | -$10.24M |